Results 61 to 70 of about 5,615 (213)

Ocular Manifestations in Dogs With Facial Nerve Dysfunction

open access: yesVeterinary Ophthalmology, Volume 29, Issue 4, July 2026.
ABSTRACT Objective To characterize the spectrum and frequency of ocular abnormalities associated with facial nerve dysfunction (FND) in dogs and to assess clinical outcomes, with specific comparison between brachycephalic (BC) and non‐brachycephalic (NBC) breeds: Methods Medical records of dogs with FND evaluated between 2009 and 2023 at the ...
L. Gaztelu, M. Leiva, T. Peña, J. Ríos
wiley   +1 more source

Summary of studies on interventions in neurotoxic envenoming.

open access: yes, 2013
Summary of studies on interventions in neurotoxic envenoming.
Udaya K. Ranawaka (469203)   +2 more
core   +1 more source

Snakebite envenoming [PDF]

open access: yesThe Lancet, 2019
Christian John, Hunter   +3 more
openaire   +5 more sources

Discovery of a Recombinant Human Monoclonal Immunoglobulin G Antibody Against α-Latrotoxin From the Mediterranean Black Widow Spider (Latrodectus tredecimguttatus)

open access: yesFrontiers in Immunology, 2020
Widow spiders are among the few spider species worldwide that can cause serious envenoming in humans. The clinical syndrome resulting from Latrodectus spp.
Sofie Føns   +8 more
doaj   +1 more source

Inflammation induced by snake venoms optimizes envenomation

open access: yesThe Journal of Physiology, Volume 604, Issue 14, Page 5831-5852, 15 July 2026.
Abstract figure legend Schematic illustrating mechanisms underlying direct vascular absorption and subsequent movement of venom toxins into the tissues consequent to snakebite. A, snakebite into prey deposits venom toxins into the tissue interstitium, with the venom then causing acute inflammation primarily in venules.
Dirk F. van Helden   +9 more
wiley   +1 more source

Cost-effectiveness of antivenoms for snakebite envenoming in Nigeria.

open access: yes, 2015
BackgroundSnakebite envenoming is a major public health problem throughout the rural tropics. Antivenom is effective in reducing mortality and remains the mainstay of therapy.
Andreas Kuznik (319101)   +12 more
core   +1 more source

Endogenous “Time Bomb” – Mislocalized Phospholipase A2 as a Critical Mediator of Ultra‐Rapid Mortality in Sepsis and Acute Lung Injury

open access: yesAdvanced Science, Volume 13, Issue 32, 9 June 2026.
Phospholipase A2 (PLA2), a dormant enzyme, becomes lethal when activated—collapsing lungs in minutes. Our dual therapy (DOPS + varespladib) boosts survival from 0% to >90% in sepsis/ALI. A breakthrough for acute lung injury treatment. ABSTRACT This study reveals that phospholipase A2 (PLA2), normally stable and nontoxic, can be activated specifically ...
Jianyu Wang   +7 more
wiley   +1 more source

Five years of snake envenoming in far north Queensland

open access: yes, 2003
Objective: To describe the epidemiology, clinical features, treatment and outcomes of patients with elapid snake envenoming in far north Queensland. Methods: Review of patients admitted with snake envenoming to Cairns Base Hospital, Queensland, from 1
Little, Mark   +3 more
core   +1 more source

Diagnosing Syndrome‐Like Microangiopathic Hemolytic Anemia After Pit Viper Envenomation: Overcoming Laboratory Gaps in a Resource‐Limited Setting: A Case Report From Nepal

open access: yesClinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Snakebite envenomation remains a significant yet often overlooked health challenge in Nepal, particularly in its rural and hilly regions. While venom‐induced consumption coagulopathy (VICC) is commonly observed with viper bites, microangiopathic hemolytic anemia (MAHA) is an extremely rare complication, especially with green pit vipers ...
Prabhat Kaphle   +10 more
wiley   +1 more source

Comparison of patients with Russell's viper envenoming and venom recurrence/persistence and non-recurrence of venom, including clinical features of envenoming, coagulopathic parameters, treatment and outcomes.

open access: yes, 2014
INR, International normalised ratio.Comparison of patients with Russell's viper envenoming and venom recurrence/persistence and non-recurrence of venom, including clinical features of envenoming, coagulopathic parameters, treatment and outcomes.
Margaret A. O'Leary (131278)   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy